Influence of age and date of infection on distribution of hepatitis C virus genotypes and fibrosis stage

Journal of Viral Hepatitis

Volumn 10, Issue 3, 2003, Pages 183-188

  Serra, Miguel A ^a,b   Rodriguez F ^a   Del Olmo, J A ^a   Escudero, A ^a   Rodrigo, J M ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Epidemiology; Fibrosis progression; HCV genotypes; Hepatitis C virus infection

Indexed keywords

VIRUS RNA;

ADULT; AGE; ALCOHOL CONSUMPTION; ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; DISEASE DURATION; EPIDEMIC; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INTRAVENOUS DRUG ABUSE; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SPAIN; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; AGING; ALCOHOL DRINKING; BLOOD TRANSFUSION; DISEASE PROGRESSION; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 0038729595     PISSN: 13520504     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2893.2003.00372.x     Document Type: Article

References (25)

1. Thomas DL, Astemborski J, Rai RM et al. The natural history of hepatitis C virus infection: host. viral, and environmental factors. JAMA 2000; 284: 2592-2593.
2. Simmonds P. Mellor J, Craxi A et al. Epidemiological, clinical and therapeutic associations of hepatitis C types in western European countries. J Hepatol 1996; 24: 517-524.
3. Bosch X. Hepatitis C outbreak astounds Spain. Lancet 1998: 351: 1415.
4. Bosch X. Newspaper apportions blame in Spanish hepatitis C scandal. Lancet 2000; 355: 818.
5. Simmonds P. Hepatitis C virus genotypes. In: Liang TJ, Hoofnagle JH. eds. Hepatitis C, Biomedical Research Reports. London: Academic Press. 2000: 53-70.
6. Batts KP, Ludwig J. Chronic hepatitis. An update on terminology and reporting. Am J Surg Pathol 1995; 19: 1409-1417.
7. Seer LB. Natural history of hepatitis. In: Liang TJ, Hoofnagle JH. eds. Hepatitis C. Biomedical Research Reports. London: Academic Press, 2000: 85-105.
8. Yano M, Kumada H, Kage M et al. The long-term pathological evolution of chronic hepatitis C. Hepatology 1996; 23: 1334-1340.
9. Gordon SC, Bayati N, Silverman AL. Clinical outcome of hepatitis C as a function of mode of transmission. Hepatology 1998; 28: 562-567.
10. Hu KQ. Tong MJ. The long-term outcomes of patients with compensated hepatitis C virus-related cirrhosis and history of parenteral exposure in the United States. Hepatology 1999; 29: 1311-1316.
11. Van Ameijden EJ. Van den Hoek JA, Mientjes GH, Coutinho RA. A longitudinal study on the incidence and transmission patterns of HIV, HBV and HCV infection among drug users in Amsterdam. Eur J Epidemiol 1993; 9: 255-262.
12. Rezza G, Sagliocca L, Zaccarelli M, Nespoli M, Siconolfi M. Baldassarre C. Incidence rate and risk factors for HCV seroconversion among injecting drug users in an area with low HIV seroprevalence. Scand J Infect Dis 1996; 28: 27-29.
13. Villano SA. Vlahov D, Nelson KE, Lyles CM, Cohn S, Thomas DL. Incidence and risk factors for hepatitis C among injection drug users in Baltimore, Maryland. J Clin Microbiol 1997; 35: 3274-3277.
14. Garfein RS. Doherty MC, Monterroso ER, Thomas DL, Nelson KE, Vlahov D. Prevalence and incidence of hepatitis C virus infection among young adult injection drug users. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 18 (Suppl, 1): S11-S19.
15. Dentico P, Curatolo N. Sacco R et al. Hepatitis C serotypes and sources of infection in patients with HCV related chronic liver disease from one geographical area in southeast Italy. Infection 1999; 27: 118-121.
16. Silini E, Bono F, Cividini A et al. Molecular epidemiology of hepatitis C infection among intravenous drug users. J Hepatol 1995; 22: 619-695.
17. Pawlotsky JM. Tsakiris L, Roudot-Thoraval F et al. Relationship between hepatitis C virus genotypes and sources of infection in patients with chronic hepatitis C. J Infect Dis 1995; 171: 1607-1610.
18. Guyader D, Lefeuvre C, Jacquelinet S et al. Epidemiologie de l'infection viral C chez 1304 sujets VHC positif. Variations en fonction du mode de contamination et l'année du diagnostic. Gastroenterol Clin Biol 1998; 22: 272-280.
19. Watson JP, Brind AM, Chapman CE et al. Hepatitis C virus: epidemiology and genotypes in the north east of England. Gut 1996; 38: 262-276.
20. Garcia F, Roldan C, Garcia F Jr et al. Subtype distribution among intravenous drug users with chronic type C hepatitis in southern Spain. Microbios 1998; 95: 15-24.
21. Ross RS, Viazov S, Renzing-Kohler K. Roggendorfg M. Changes in the epidemiology of hepatitis C infection in Germany: shift in the predominance of hepatitis C subtypes. J Med Virol 2000; 60: 122-125.
22. Pol S, Thiers V, Nousbaum JB. Legendre C, Berthelot P, Kreis H. Brechot C. The changing relative prevalence of hepatitis C virus genotypes: evidence in hemodialyzed patients and kidney recipients. Gastroenterology 1995: 108: 581-583.
23. Mahaney K. Tedeschi V. Maertens G et al. Genotypic analysis of hepatitis C virus in American patients. Hepatology 1994; 20: 1405-1411.
24. Poynard T, Bedossa P. Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC. METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 1997; 349: 825-832.
25. Asselah T, Martinot M. Boyer N, Marcellin P. Genetic variability of hepatitis C virus. Gastroenterol Clin Biol 2000; 24: 175-184.